Search

everythinglearnresearchcommunity

for

Search:↓

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Serum biomarkers like insulin-like growth factor-1 and vitamin D may help diagnose androgenetic alopecia.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Topical finasteride doesn't reduce DHT levels, hinting at an endocrine role in hair loss.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Finasteride reduces prostate size and PSA levels in young patients.

Putting calcipotriol ointment on the skin once doesn't change calcium levels in the body right away.

The normal human prostate does not significantly affect blood DHT levels.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

Low estrogen compared to androgen may cause female hair loss.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.